Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
ImmunoTargets and Therapy · 2026-05 · Volume 15 · 1-11
DOI: 10.2147/itt.s594176 ↗Kurz gefasst
Fallbericht in der Zeitschrift ImmunoTargets and Therapy, 2026-05. Verfasst von Sebastian Meltzer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Akershus University Hospital, Lørenskog, Norway. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
- Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Radiology, Akershus University Hospital, Lørenskog, Norway.
- Department of Research, Sørlandet Hospital, Kristiansand, Norway.
- Department of Oncology, St. Olav's Hospital, Trondheim, Norway.
ORCID-Profile: Sebastian Meltzer, Jūratė Šaltytė Benth, Anne Negård, Hanne Mari Hamre, Christian Kersten, Eva Hofsli, Marianne Grønlie Guren, Halfdan Sorbye, Kjersti Flatmark, Anne Hansen Ree
Zitieren
APA
Meltzer, S., Landmark, S. S., Šaltytė Benth, J., Negård, A., Hamre, H. M., Kersten, C., Hofsli, E., Guren, M. G., Sorbye, H., Flatmark, K., & Ree, A. H. (2026). Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data. ImmunoTargets and Therapy, Volume 15, 1-11. https://doi.org/10.2147/itt.s594176
Vancouver
Meltzer S, Landmark SS, Šaltytė Benth J, Negård A, Hamre HM, Kersten C, et al. Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data. ImmunoTargets and Therapy. 2026;Volume 15:1-11. doi:10.2147/itt.s594176
BibTeX
@article{Meltzer2026,
author = {Meltzer, Sebastian and Landmark, Silje Sjåvik and Šaltytė Benth, Jūratė and Negård, Anne and Hamre, Hanne Mari and Kersten, Christian and Hofsli, Eva and Guren, Marianne Grønlie and Sorbye, Halfdan and Flatmark, Kjersti and Ree, Anne Hansen},
title = {Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data},
journal = {ImmunoTargets and Therapy},
year = {2026},
volume = {Volume 15},
pages = {1--11},
doi = {10.2147/itt.s594176}
}
EUVIMED